Omar Salamanca, MD, staff ophthalmologist, Orbis Flying Eye Hospital, discusses Orbis's tailored glaucoma training programs, which focus on hands-on surgical skills, early detection, telemedicine, and ...
FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.
The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).
The investigators conducted a randomized controlled trial of 60 patients who underwent monitored anesthesia care sedation for ...
In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...
Robert T. Chang, MD, from Stanford University discusses how large language models are transforming ophthalmology by enhancing ...
The phase 3 trial was conducted by licensee, Grand Pharma in Chinese cataract surgery patients. Formosa Pharmaceuticals has ...
Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.
200 mg of caffeine elevated the blood pressure after 2 hours but did not impact the retinal VD.
A group of German researchers has discovered how tiny eye movements and the density of photoreceptors assist in visual acuity ...
The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 Impairment of the retinal deep capillary plexus also occurs and suggests ...
Alfredo Sadun, MD, PhD, is the chief of Ophthalmology at the Doheny Eye Institute of UCLA. At this year's AAO meeting held in Chicago, Illinois, he stopped by the Eye Care Network booth to share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback